Chinese company to use AI-powered chromosome testing to boost profits and fast track IVF
Story summaryChina’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million after Hong Kong listing
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.